Selected research
Industry Research
Drug Discovery AI Tools Industry Research Report 2026
Market perspective
The global Drug Discovery AI Tools market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Drug Discovery AI Tools market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Discovery AI Tools market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Discovery AI Tools market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Discovery AI Tools include Exscientia, Insilico Medicine, Valo Health, Owkin, XtalPi, Healx, Atomwise, BenevolentAI and Recursion. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Drug Discovery AI Tools market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Discovery AI Tools.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Discovery AI Tools Market by Company
Exscientia
Insilico Medicine
Valo Health
Owkin
XtalPi
Healx
Atomwise
BenevolentAI
Recursion
Drug Discovery AI Tools Segment by Type
Drug Target Identification
Compound Screening
Efficacy Prediction
Clinical Trial Optimization
Drug Discovery AI Tools Segment by Application
Contract Research Organizations
Research Centers and Academic Institutes
Pharmaceutical and Biotechnology Companies
Drug Discovery AI Tools Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Discovery AI Tools market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Discovery AI Tools and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Discovery AI Tools.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Discovery AI Tools companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drug Target Identification
- Compound Screening
- Efficacy Prediction
- Clinical Trial Optimization
Applications
- Contract Research Organizations
- Research Centers and Academic Institutes
- Pharmaceutical and Biotechnology Companies
Companies covered
- Exscientia
- Insilico Medicine
- Valo Health
- Owkin
- XtalPi
- Healx
- Atomwise
- BenevolentAI
- Recursion
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Discovery AI Tools by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Drug Target Identification
- 2.2.3 Compound Screening
- 2.2.4 Efficacy Prediction
- 2.2.5 Clinical Trial Optimization
- 2.3 Drug Discovery AI Tools by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Contract Research Organizations
- 2.3.3 Research Centers and Academic Institutes
- 2.3.4 Pharmaceutical and Biotechnology Companies
- 2.4 Assumptions and Limitations
3 Drug Discovery AI Tools Breakdown Data by Type
- 3.1 Global Drug Discovery AI Tools Historic Market Size by Type (2021-2026)
- 3.2 Global Drug Discovery AI Tools Forecasted Market Size by Type (2027-2032)
4 Drug Discovery AI Tools Breakdown Data by Application
- 4.1 Global Drug Discovery AI Tools Historic Market Size by Application (2021-2026)
- 4.2 Global Drug Discovery AI Tools Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug Discovery AI Tools Market Perspective (2021-2032)
- 5.2 Global Drug Discovery AI Tools Growth Trends by Region
- 5.2.1 Global Drug Discovery AI Tools Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug Discovery AI Tools Historic Market Size by Region (2021-2026)
- 5.2.3 Drug Discovery AI Tools Forecasted Market Size by Region (2027-2032)
- 5.3 Drug Discovery AI Tools Market Dynamics
- 5.3.1 Drug Discovery AI Tools Industry Trends
- 5.3.2 Drug Discovery AI Tools Market Drivers
- 5.3.3 Drug Discovery AI Tools Market Challenges
- 5.3.4 Drug Discovery AI Tools Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug Discovery AI Tools Players by Revenue
- 6.1.1 Global Top Drug Discovery AI Tools Players by Revenue (2021-2026)
- 6.1.2 Global Drug Discovery AI Tools Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug Discovery AI Tools Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug Discovery AI Tools Head Office and Area Served
- 6.4 Global Drug Discovery AI Tools Players, Product Type & Application
- 6.5 Global Drug Discovery AI Tools Manufacturers Established Date
- 6.6 Global Drug Discovery AI Tools Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug Discovery AI Tools Market Size (2021-2032)
- 7.2 North America Drug Discovery AI Tools Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug Discovery AI Tools Market Size by Country (2021-2026)
- 7.4 North America Drug Discovery AI Tools Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug Discovery AI Tools Market Size (2021-2032)
- 8.2 Europe Drug Discovery AI Tools Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug Discovery AI Tools Market Size by Country (2021-2026)
- 8.4 Europe Drug Discovery AI Tools Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Discovery AI Tools Market Size (2021-2032)
- 9.2 Asia-Pacific Drug Discovery AI Tools Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug Discovery AI Tools Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug Discovery AI Tools Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug Discovery AI Tools Market Size (2021-2032)
- 10.2 South America Drug Discovery AI Tools Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug Discovery AI Tools Market Size by Country (2021-2026)
- 10.4 South America Drug Discovery AI Tools Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Discovery AI Tools Market Size (2021-2032)
- 11.2 Middle East & Africa Drug Discovery AI Tools Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug Discovery AI Tools Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug Discovery AI Tools Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Exscientia
- 12.1.1 Exscientia Company Information
- 12.1.2 Exscientia Business Overview
- 12.1.3 Exscientia Revenue in Drug Discovery AI Tools Business (2021-2026)
- 12.1.4 Exscientia Drug Discovery AI Tools Product Portfolio
- 12.1.5 Exscientia Recent Developments
- 12.2 Insilico Medicine
- 12.2.1 Insilico Medicine Company Information
- 12.2.2 Insilico Medicine Business Overview
- 12.2.3 Insilico Medicine Revenue in Drug Discovery AI Tools Business (2021-2026)
- 12.2.4 Insilico Medicine Drug Discovery AI Tools Product Portfolio
- 12.2.5 Insilico Medicine Recent Developments
- 12.3 Valo Health
- 12.3.1 Valo Health Company Information
- 12.3.2 Valo Health Business Overview
- 12.3.3 Valo Health Revenue in Drug Discovery AI Tools Business (2021-2026)
- 12.3.4 Valo Health Drug Discovery AI Tools Product Portfolio
- 12.3.5 Valo Health Recent Developments
- 12.4 Owkin
- 12.4.1 Owkin Company Information
- 12.4.2 Owkin Business Overview
- 12.4.3 Owkin Revenue in Drug Discovery AI Tools Business (2021-2026)
- 12.4.4 Owkin Drug Discovery AI Tools Product Portfolio
- 12.4.5 Owkin Recent Developments
- 12.5 XtalPi
- 12.5.1 XtalPi Company Information
- 12.5.2 XtalPi Business Overview
- 12.5.3 XtalPi Revenue in Drug Discovery AI Tools Business (2021-2026)
- 12.5.4 XtalPi Drug Discovery AI Tools Product Portfolio
- 12.5.5 XtalPi Recent Developments
- 12.6 Healx
- 12.6.1 Healx Company Information
- 12.6.2 Healx Business Overview
- 12.6.3 Healx Revenue in Drug Discovery AI Tools Business (2021-2026)
- 12.6.4 Healx Drug Discovery AI Tools Product Portfolio
- 12.6.5 Healx Recent Developments
- 12.7 Atomwise
- 12.7.1 Atomwise Company Information
- 12.7.2 Atomwise Business Overview
- 12.7.3 Atomwise Revenue in Drug Discovery AI Tools Business (2021-2026)
- 12.7.4 Atomwise Drug Discovery AI Tools Product Portfolio
- 12.7.5 Atomwise Recent Developments
- 12.8 BenevolentAI
- 12.8.1 BenevolentAI Company Information
- 12.8.2 BenevolentAI Business Overview
- 12.8.3 BenevolentAI Revenue in Drug Discovery AI Tools Business (2021-2026)
- 12.8.4 BenevolentAI Drug Discovery AI Tools Product Portfolio
- 12.8.5 BenevolentAI Recent Developments
- 12.9 Recursion
- 12.9.1 Recursion Company Information
- 12.9.2 Recursion Business Overview
- 12.9.3 Recursion Revenue in Drug Discovery AI Tools Business (2021-2026)
- 12.9.4 Recursion Drug Discovery AI Tools Product Portfolio
- 12.9.5 Recursion Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst